Print this page    •   Back to Web version of article

IAPAC Monthly
Table of Contents, January 2003

IAPAC Monthly magazine


Report From the President
Routing Out Indifference
By José M. Zuniga

In the News
IAPAC Commits to "Fast Action" in Face of Global Challenges
By Scott A. Wolfe

Time to Move on HIV/AIDS Treatment and Care
By Bernhard Schwartländer and Joep M.A. Lange


In the Life
Claire Touchie

Say Anything

Heavy Lifting in Glasgow (Wherein HIV Researchers Uncrate Some Clydeside Surprises)
After a year of meetings rife with HIV treatment news, how much can you expect from the Glasgow congress? Plenty. Pharmacokinetic curiosities included d4T triphosphate in people taking AZT, and indinavir/ritonavir lite -- 400/100 mg twice a day. A clutch of clinic reports agreed that long responders are replacing nonresponders, while other studies showed how T-cell counts sway STI results. New drugs on the agenda included T-20, atazanavir, and amprenavir's prodrug.
By Mark Mascolini

Editor-in-Chief: José M. Zuniga

Managing Editor: Lisa McKamy

Political Editor: Scott A. Wolfe

Creative/Design Director: Holly J. Emanuelson

Advertising Director: Michael S. Glass

Writer-at-Large: Mark Mascolini

Contributing Writers: Lisa Keen, Dave MacDougall

IAPAC Monthly
33 N. LaSalle, Suite 1700
Chicago, IL 60602-2601, USA
Fax: (212) 367-1528
©2003 IAPAC Monthly

This article was provided by International Association of Physicians in AIDS Care. It is a part of the publication IAPAC Monthly. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.